Medicina
Candidate of Medical Sciences Beisen N.E.
National Welfare Fund"
Samruk-Kazyna ", Astana
Features
of the organization of drug supply of the Republic of Kazakhstan
The right to health in the Republic
of Kazakhstan (RK) is fixed by the Constitution and implies the equal rights of
citizens to safe, effective and quality health care (HC) [1]. Drug supply (DS)
- one of the most important components of the MP and no small measure of social
support, directly contributing to improving the health and quality of life [2].
The main mission of the pharmaceutical market in Kazakhstan is to provide the
population with quality and affordable medicines (drugs) [3].
Existed in the late 90s in Kazakhstan rigidly centralized system of public
provision of public drug was completely destroyed, and formed the
organizational and economic relations in the sphere of drug trafficking were
not able to ensure the implementation of one of the fundamental human rights
guaranteed by international law and the Constitution of Kazakhstan - the right
health. The ongoing reform of the EA population and health care institutions
are not allowed to solve the problem of local drug production and availability
of imported pharmaceuticals, resulting in approximately 75% of the citizens of
Kazakhstan did not receive adequate medical therapy, and the sphere of drug
trafficking are increasingly attracted the attention of criminal organizations,
especially in terms of fraud drugs that counter to the objectives of social and
economic security [4].
In Kazakhstan, the question has risen most sharply since the beginning of
the 90s of XX century, when both appeared unfavorable trends in terms of public
health and in our market appeared counterfeit drugs. Against the backdrop of
unfavorable trends in terms of public health criminalization of trafficking in
drugs became more and more threatening. At present, in the form of DS RK is the
formulary system, which is based on drug selection with the best combination of
"security applications - the effectiveness of the treatment - the cost of
treatment," and they are being rational use of the health system.
The state is now an active player in the Kazakhstan pharmaceutical market,
but not only in terms of legal regulation, but also as sofinansist drug
consumption. In order to effectively manage inventory, quality LO population,
the Government of the Republic of Kazakhstan, as part of the National Fund of
the welfare of the people "Samruk-Kazyna" in 2009 created the
"SK-Pharmacy", designed to address the major challenges LO population
in the framework of the guaranteed health care (GHC) to the population as a
single distributor (ED). In accordance with the objectives set out in the
Charter of the "SK-Pharmacy", ED manages inventory, including -
Purchase, storage, distribution and supply of quality drugs and medical
products (medical devices) as part of free health care
[5].
Used in the " SK -Pharmacy" methodological and logistical tools
to manage inventory to provide state-guaranteed MRE programs provide equity and
increase the access of the population to the most important drugs [6].
In this case, the most important factors that influence the above processes
are the following processes: the definition of a real need for outpatient drugs
and inpatient MO-based accounting change targets of various diseases and
populations of certain categories of citizens in need of subsidized drug
coverage; commissioning brand new high-tech medical institutions using
international standards of pharmaceutical care; underdeveloped domestic
pharmaceutical industry and others [7].
The domestic pharmaceutical production is generink, the market demand for
innovative drugs is met through imports (up 70% in value terms). Increasing
competition from foreign manufacturers significantly complicates the process of
organization and sales management in enterprises, obtaining competitive
advantage made possible with the concentration of domestic producers with other
participants of the pharmaceutical market, through vertical and horizontal integration
in a large holding structure [8].
The main specific features of today's pharmaceutical market in the Republic
of Kazakhstan, the presence of centralized drug procurement budget: 40% traded
on the pharmaceutical drug market (including the full cost of hospital segment)
to be paid from the budget.
In the current model of inventory management using the core model of the
interaction Consumer - Supplier. When using the model, which is the central
figure of the consumer data is delivered directly to the consumer, which
greatly facilitates the task of getting the information it needs.
Markets of developing countries, including Kazakhstan, are subject to
economic, political, social, legal and legislative risks, different risks than
more developed markets. The current system of the Republic of Kazakhstan to the
centralization of LO when filling drug programs through SBP Single distributor
"SK-Pharmacy", allows for more efficient use of health care resources
and social protection of the poor.
Thus, in the organization of the RK LO underwent changes, improved, and
operating circuit pharmaceutical supply of the population has effective
controls inventory. Feature of the organization is to centralize LO RK filling
in drug programs through free health care single distributor
"SK-Pharmacy»,
which allows for more efficient use of health care resources.
References
1. The Constitution of the Republic of Kazakhstan chapter 2, paragraph 1,
Article 4 of the Code of the Republic of Kazakhstan "On Public Health and
the Health Care System"
2. State Program for Development of Health of the Republic of Kazakhstan
"Kazakhstan Salamatty" on 2011 - 2015 years
3. On the state of the
pharmaceutical industry in Kazakhstan. MOH. – Oct., 2012.
4. Pharmacovigilance and monitoring of side effects of drugs in Kazakhstan.
Report RSE "NTSELS" MH RK.2011g.
5. Charter
"SK-Pharmacy" .2009, the
6. Tashbaev Y.E. No there is no effective logistics business / / Pharm.
Gazette, 2002. - ¹ 11 (250)
7. Beloshapka VA Strategic management and marketing practices of pharmaceutical
companies / / Kiev: Triumph, 2011. 368 p.
8. Nevolina EV The quality management system in the pharmacy organization / /
New Pharmacy. 2008. Number 12. S. 61-70.
Abstract
Candidate of Medical Sciences Beisen N.E.
Features of the
organization of drug supply of the Republic of Kazakhstan
This paper presents an overview of
the dynamic changes in drug coverage citizens of the Republic of Kazakhstan,
taking place in recent decades. It shows the current system and its basic
principles. In this case demonstrated that the centralization of filling in
drug programs through SBP Single distributor "SK-Pharmacy" allows for
more efficient use of health care resources.
Keywords: drug provision, the right to health, centralized, single
distributor, the effectiveness of